VHL and cancer: Our prior investigation in eupoloid primary ES cell lines, utilized as a strategy to avoid interference from transforming cancer cell events, demonstrated a bias toward HIF-2α dysregulation for VHL Type 2B mutation, and a graduated degree of HIF dysregulation across the disease subtypes [25].